Medicine
Peter Nash has not added Biography.
If you are Peter Nash and would like to personalize this page please email our Author Liaison for assistance.
Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research May, 2003 | Pubmed ID: 12733733
Assessment of patients with psoriatic arthritis: a review of currently available measures.
Arthritis and rheumatism Jan, 2004 | Pubmed ID: 14730596
Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.
Arthritis and rheumatism Jun, 2004 | Pubmed ID: 15188371
Tumour necrosis factor inhibitors.
The Medical journal of Australia Aug, 2005 | Pubmed ID: 16097922
Outcome measures in psoriatic arthritis.
The Journal of rheumatology Nov, 2005 | Pubmed ID: 16265714
Leflunomide improves psoriasis in patients with psoriatic arthritis: an in-depth analysis of data from the TOPAS study.
Dermatology (Basel, Switzerland) , 2006 | Pubmed ID: 16549920
Therapies for axial disease in psoriatic arthritis. A systematic review.
The Journal of rheumatology Jul, 2006 | Pubmed ID: 16724371
Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial.
Lancet (London, England) Sep, 2006 | Pubmed ID: 16950363
Alefacept plus methotrexate for psoriatic arthritis.
Nature clinical practice. Rheumatology Sep, 2006 | Pubmed ID: 16951699
Outcome measures in psoriatic arthritis.
The Journal of rheumatology May, 2007 | Pubmed ID: 17477479
Consensus on a core set of domains for psoriatic arthritis.
The Journal of rheumatology May, 2007 | Pubmed ID: 17477480
Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study.
Arthritis and rheumatism Apr, 2008 | Pubmed ID: 18383539
Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis.
Arthritis and rheumatism Jun, 2008 | Pubmed ID: 18512721
Initiative for quality in psoriasis and psoriatic arthritis.
The Journal of rheumatology Jul, 2008 | Pubmed ID: 18609739
Drug use and toxicity in psoriatic disease: focus on methotrexate.
The Journal of rheumatology Jul, 2008 | Pubmed ID: 18609744
Population rates of bone densitometry use in Australia, 2001-2005, by sex and rural versus urban location.
The Medical journal of Australia Feb, 2009 | Pubmed ID: 19203308
Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis.
Arthritis and rheumatism Aug, 2009 | Pubmed ID: 19644849
Assessment and treatment of psoriatic spondylitis.
Current rheumatology reports Aug, 2009 | Pubmed ID: 19691931
Inappropriate prescribing for osteoporosis.
The Medical journal of Australia Sep, 2009 | Pubmed ID: 19769562
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
The Journal of rheumatology Oct, 2009 | Pubmed ID: 19820225
Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group.
The Journal of rheumatology Jan, 2010 | Pubmed ID: 19955042
The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy.
International journal of rheumatic diseases Sep, 2009 | Pubmed ID: 20374346
Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group.
Annals of the rheumatic diseases Jul, 2010 | Pubmed ID: 20472586
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis.
Clinical and experimental rheumatology Mar-Apr, 2010 | Pubmed ID: 20576214
Effect of psoriatic arthritis according to the affected categories of the international classification of functioning, disability and health.
The Journal of rheumatology Sep, 2010 | Pubmed ID: 20595273
Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in Australian patients: A cross-sectional, multicenter study.
Clinical therapeutics Jul, 2010 | Pubmed ID: 20678681
Registries in systemic sclerosis: a worldwide experience.
Rheumatology (Oxford, England) Jan, 2011 | Pubmed ID: 21148153
Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed.
Arthritis research & therapy , 2011 | Pubmed ID: 21699746
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
The Journal of rheumatology Nov, 2011 | Pubmed ID: 21965635
Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.
Arthritis research & therapy , 2011 | Pubmed ID: 22189167
N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
Arthritis research & therapy , 2012 | Pubmed ID: 22691291
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project).
Annals of the rheumatic diseases Jun, 2013 | Pubmed ID: 22798567
Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.
Rheumatology (Oxford, England) Jan, 2013 | Pubmed ID: 23065360
Immunogenicity, safety, and efficacy of abatacept administered subcutaneously with or without background methotrexate in patients with rheumatoid arthritis: results from a phase III, international, multicenter, parallel-arm, open-label study.
Arthritis care & research May, 2013 | Pubmed ID: 23097311
Cellular blue naevus involving the urinary bladder.
Pathology Dec, 2012 | Pubmed ID: 23172087
Treatment goals for moderate to severe psoriasis: an Australian consensus.
The Australasian journal of dermatology May, 2013 | Pubmed ID: 23330815
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
Lancet (London, England) Mar, 2013 | Pubmed ID: 23332236
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study.
Arthritis and rheumatism Mar, 2013 | Pubmed ID: 23348607
Golimumab, a human anti–tumor necrosis factor monoclonal antibody, injected subcutaneously every 4 weeks in patients with active rheumatoid arthritis who had never taken methotrexate: 1-year and 2-year clinical, radiologic, and physical function findings of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Arthritis care & research Nov, 2013 | Pubmed ID: 23861303
New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.
Journal of virology Feb, 2014 | Pubmed ID: 24198411
Nutrient regulation by continuous feeding removes limitations on cell yield in the large-scale expansion of Mammalian cell spheroids.
PloS one , 2013 | Pubmed ID: 24204645
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.
Arthritis research & therapy , 2013 | Pubmed ID: 24246100
Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
International journal of rheumatic diseases Dec, 2013 | Pubmed ID: 24382276
Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?
Inflammatory bowel diseases Apr, 2014 | Pubmed ID: 24572206
Subcutaneous abatacept for the treatment of rheumatoid arthritis: longterm data from the ACQUIRE trial.
The Journal of rheumatology Apr, 2014 | Pubmed ID: 24584926
Long-term safety of subcutaneous abatacept in rheumatoid arthritis: integrated analysis of clinical trial data representing more than four years of treatment.
Arthritis & rheumatology (Hoboken, N.J.) Aug, 2014 | Pubmed ID: 24782324
Professional boundaries in learning disability care.
Nursing times May 21-27, 2014 | Pubmed ID: 24960974
An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3.
Arthritis research & therapy , 2014 | Pubmed ID: 25332064
Updated guidelines for the management of axial disease in psoriatic arthritis.
The Journal of rheumatology Nov, 2014 | Pubmed ID: 25362712
Rheumatoid arthritis in the Middle East and Africa: are we any closer to optimising its management?
Clinical rheumatology Jan, 2015 | Pubmed ID: 25376467
A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.
Arthritis research & therapy , 2015 | Pubmed ID: 25596924
Treatment Algorithms in Systemic Lupus Erythematosus.
Arthritis care & research Sep, 2015 | Pubmed ID: 25777803
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.
Annals of the rheumatic diseases Jan, 2016 | Pubmed ID: 25969430
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update.
Annals of the rheumatic diseases Jan, 2016 | Pubmed ID: 25990290
Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.
Clinical and experimental rheumatology Jul-Aug, 2015 | Pubmed ID: 26243401
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs.
Annals of the rheumatic diseases Jul, 2016 | Pubmed ID: 26275429
APLAR rheumatoid arthritis treatment recommendations.
International journal of rheumatic diseases Sep, 2015 | Pubmed ID: 26334449
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.
The New England journal of medicine Oct, 2015 | Pubmed ID: 26422723
Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial.
Arthritis care & research Jun, 2016 | Pubmed ID: 26474452
Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
BJU international Apr, 2016 | Pubmed ID: 26486968
Reply.
Arthritis care & research Jul, 2016 | Pubmed ID: 26555102
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.
Arthritis & rheumatology (Hoboken, N.J.) May, 2016 | Pubmed ID: 26749174
Learning disabilities: improved bowel screening.
Nursing times Dec 2-15, 2015 | Pubmed ID: 26841578
The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
Clinical and experimental rheumatology May, 2016 | Pubmed ID: 27214686
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유